EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Fighting fibrin with fibrin: Vancomycin delivery into coagulase‐mediated Staphylococcus aureus biofilms via fibrin‐based nanoparticle binding

Grant Scull, Adrian Aligwekwe, Ysabel Rey, Drew Koch, Kimberly Nellenbach, Ana Sheridan, Sanika Pandit, Jennifer Sollinger, Joshua G Pierce, Matthew J Flick, Jessica Gilbertie, Lauren Schnabel und 1 weitere

Journal of Biomedical Materials Research Part A · 2024-12 · 112 (12) · 2071-2085

DOI: 10.1002/jbm.a.37760 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part A, online erschienen am 14.06.2024. Verfasst von Grant Scull und 12 weiteren Autor:innen. Beteiligte Einrichtung: Joint Department of Biomedical Engineering, NC State University and UNC-Chapel Hill, Raleigh, North Carolina, USA. Hauptthemen laut MEDLINE: Vancomycin, Biofilms, Fibrin, Staphylococcus aureus. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Staphylococcus aureus skin and soft tissue infection is a common ailment placing a large burden upon global healthcare infrastructure. These bacteria are growing increasingly recalcitrant to frontline antimicrobial therapeutics like vancomycin due to the prevalence of variant populations such as methicillin‐resistant and vancomycin‐resistant strains, and there is currently a dearth of novel antibiotics in production. Additionally, S. aureus has the capacity to hijack the host clotting machinery to generate fibrin‐based biofilms that confer protection from host antimicrobial mechanisms and antibiotic‐based therapies, enabling immune system evasion and significantly reducing antimicrobial efficacy. Emphasis is being placed on improving the effectiveness of therapeutics that are already commercially available through various means. Fibrin‐based nanoparticles (FBNs) were developed and found to interact with S. aureus through the clumping factor A (ClfA) fibrinogen receptor and directly integrate into the biofilm matrix. FBNs loaded with antimicrobials such as vancomycin enabled a targeted and sustained release of antibiotic that increased drug contact time and reduced the therapeutic dose required for eradicating the bacteria, both in vitro and in vivo. Collectively, these findings suggest that FBN‐antibiotic delivery may be a novel and potent therapeutic tool for the treatment of S. aureus biofilm infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VancomycinBiofilmsFibrinStaphylococcus aureusCoagulaseNanoparticlesAnimalsAnti-Bacterial AgentsHumansStaphylococcal InfectionsMice

Stichwörter der Autor:innen

Staphylococcus aureusbiofilmdermal infectionfibrinnanoparticlevancomycin

Substanzen

VancomycinFibrinCoagulaseAnti-Bacterial Agents

Autor:innen und Institutionen

  • Joint Department of Biomedical Engineering, NC State University and UNC-Chapel Hill, Raleigh, North Carolina, USA.
  • Comparative Medicine Institute, NC State University, Raleigh, North Carolina, USA.
  • College of Veterinary Medicine, NC State University, Raleigh, North Carolina, USA.
  • Department of Chemistry, NC State University, Raleigh, North Carolina, USA.
  • UNC-Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
  • Blood Research Center, UNC-Chapel Hill, Chapel Hill, NC, USA.

ORCID-Profile: Ashley C Brown

Förderung

  • NIGMS NIH HHS
  • NIH HHS
  • NHLBI NIH HHS
  • NSF
  • National Institutes of Health
  • National Science Foundation

Zitieren

APA

Scull, G., Aligwekwe, A., Rey, Y., Koch, D., Nellenbach, K., Sheridan, A., Pandit, S., Sollinger, J., Pierce, J. G., Flick, M. J., Gilbertie, J., Schnabel, L., & Brown, A. C. (2024). Fighting fibrin with fibrin: Vancomycin delivery into coagulase‐mediated Staphylococcus aureus biofilms via fibrin‐based nanoparticle binding. Journal of Biomedical Materials Research Part A, 112(12), 2071-2085. https://doi.org/10.1002/jbm.a.37760

Vancouver

Scull G, Aligwekwe A, Rey Y, Koch D, Nellenbach K, Sheridan A, et al. Fighting fibrin with fibrin: Vancomycin delivery into coagulase‐mediated Staphylococcus aureus biofilms via fibrin‐based nanoparticle binding. Journal of Biomedical Materials Research Part A. 2024;112(12):2071-2085. doi:10.1002/jbm.a.37760

BibTeX
@article{Scull2024,
  author = {Scull, Grant and Aligwekwe, Adrian and Rey, Ysabel and Koch, Drew and Nellenbach, Kimberly and Sheridan, Ana and Pandit, Sanika and Sollinger, Jennifer and Pierce, Joshua G and Flick, Matthew J and Gilbertie, Jessica and Schnabel, Lauren and Brown, Ashley C},
  title = {Fighting fibrin with fibrin: Vancomycin delivery into coagulase‐mediated Staphylococcus aureus biofilms via fibrin‐based nanoparticle binding},
  journal = {Journal of Biomedical Materials Research Part A},
  year = {2024},
  volume = {112},
  number = {12},
  pages = {2071--2085},
  doi = {10.1002/jbm.a.37760}
}
Kostenlos starten →